Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a single-center experience with 63 patients.

I Nieto-AristizábalT MartínezM-A UrbanoI Posso-OsorioI F PlataJ E Garcia-RobledoC C AragónV A SantosGabriel J Tobón

Published in: Lupus (2019)

IVIG showed adequate tolerance and effectiveness in selected severe SLE manifestations, mainly hematological involvement. It was useful for concomitant infection.

Keyphrases

end stage renal disease
ejection fraction
systemic lupus erythematosus
chronic kidney disease
newly diagnosed
randomized controlled trial
systematic review
prognostic factors
peritoneal dialysis
early onset
rheumatoid arthritis
patient reported outcomes
patient reported
smoking cessation